{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:17:18Z","timestamp":1794284238962,"version":"4.9.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["452145"],"award-info":[{"award-number":["452145"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systematic reviews of outcome measurement instruments are important tools in the evidence-based selection of these instruments. COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) has developed a comprehensive and widespread guideline to conduct systematic reviews of outcome measurement instruments, but key information is often missing in published reviews. This hinders the appraisal of the quality of outcome measurement instruments, impacts the decisions of knowledge users regarding their appropriateness, and compromises reproducibility and interpretability of the reviews\u2019 findings. To facilitate sufficient, transparent, and consistent reporting of systematic reviews of outcome measurement instruments, an extension of the PRISMA (Preferred Reporting of Items for Systematic reviews and Meta-Analyses) 2020 guideline will be developed: the PRISMA-COSMIN guideline.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The PRISMA-COSMIN guideline will be developed in accordance with recommendations for reporting guideline development from the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network. First, a candidate reporting item list will be created through an environmental literature scan and expert consultations. Second, an international Delphi study will be conducted with systematic review authors, biostatisticians, epidemiologists, psychometricians\/clinimetricians, reporting guideline developers, journal editors as well as patients, caregivers, and members of the public. Delphi panelists will rate candidate items for inclusion on a 5-point scale, suggest additional candidate items, and give feedback on item wording and comprehensibility. Third, the draft PRISMA-COSMIN guideline and user manual will be iteratively piloted by applying it to systematic reviews in several disease areas to assess its relevance, comprehensiveness, and comprehensibility, along with usability and user satisfaction. Fourth, a consensus meeting will be held to finalize the PRISMA-COSMIN guideline through roundtable discussions and voting. Last, a user manual will be developed and the final PRISMA-COSMIN guideline will be disseminated through publications, conferences, newsletters, and relevant websites. Additionally, relevant journals and organizations will be invited to endorse and implement PRISMA-COSMIN. Throughout the project, evaluations will take place to identify barriers and facilitators of involving patient\/public partners and employing a virtual process.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The PRISMA-COSMIN guideline will ensure that the reports of systematic reviews of outcome measurement instruments are complete and informative, enhancing their reproducibility, ease of use, and uptake.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-022-01994-5","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T12:23:32Z","timestamp":1655123012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0680-6430","authenticated-orcid":false,"given":"Ellen B. M.","family":"Elsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidwine B.","family":"Mokkink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline B.","family":"Terwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel J.","family":"Gagnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalekan Lee","family":"Aiyegbusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Offringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"issue":"26","key":"1994_CR1","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","volume":"363","author":"ME Porter","year":"2010","unstructured":"Porter ME. What is value in health care. N Engl J Med. 2010;363(26):2477\u201381.","journal-title":"N Engl J Med"},{"key":"1994_CR2","doi-asserted-by":"publisher","first-page":"g7818","DOI":"10.1136\/bmj.g7818","volume":"350","author":"EC Nelson","year":"2015","unstructured":"Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S. Patient reported outcome measures in practice. BMJ. 2015;350:g7818.","journal-title":"BMJ."},{"key":"1994_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jclinepi.2020.06.013","volume":"126","author":"EJ Mew","year":"2020","unstructured":"Mew EJ, Monsour A, Saeed L, Santos L, Patel S, Courtney DB, et al. Systematic scoping review identifies heterogeneity in outcomes measured in adolescent depression clinical trials. J Clin Epidemiol. 2020;126:71\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"1994_CR4","doi-asserted-by":"publisher","first-page":"e014610","DOI":"10.1136\/bmjopen-2016-014610","volume":"7","author":"SK Ardestani","year":"2017","unstructured":"Ardestani SK, Karkhaneh M, Yu HC, Hydrie MZI, Vohra S. Primary outcomes reporting in trials of paediatric type 1 diabetes mellitus: a systematic review. BMJ Open. 2017;7(12):e014610.","journal-title":"BMJ Open"},{"issue":"1","key":"1994_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/archdischild-2019-316823","volume":"105","author":"JWH Webbe","year":"2020","unstructured":"Webbe JWH, Ali S, Sakonidou S, Webbe T, Duffy JM, Brunton G, et al. Inconsistent outcome reporting in large neonatal trials: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2020;105(1):69\u201375.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"1994_CR6","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.jclinepi.2015.06.006","volume":"68","author":"MJ Page","year":"2015","unstructured":"Page MJ, McKenzie JE, Green SE, Beaton DE, Jain NB, Lenza M, et al. Core domain and outcome measurement sets for shoulder pain trials are needed: systematic review of physical therapy trials. J Clin Epidemiol. 2015;68(11):1270\u201381.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"1994_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737\u201345.","journal-title":"J Clin Epidemiol"},{"key":"1994_CR8","unstructured":"COSMIN. COSMIN database of systematic reviews. www.cosmin.nl\/tools\/database-systematic-reviews\/. Accessed 30 Jan 2022."},{"issue":"5","key":"1994_CR9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","volume":"27","author":"CA Prinsen","year":"2018","unstructured":"Prinsen CA, Mokkink LB, Bouter LM, Alonso J, Patrick DL, De Vet HC, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147\u201357.","journal-title":"Qual Life Res"},{"issue":"5","key":"1994_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","volume":"27","author":"CB Terwee","year":"2018","unstructured":"Terwee CB, Prinsen CA, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27(5):1159\u201370.","journal-title":"Qual Life Res"},{"issue":"1","key":"1994_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-020-01179-5","volume":"20","author":"LB Mokkink","year":"2020","unstructured":"Mokkink LB, Boers M, van der Vleuten C, Bouter LM, Alonso J, Patrick DL, et al. COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi study. BMC Med Res Methodol. 2020;20(1):1\u201313.","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"1994_CR12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","volume":"27","author":"LB Mokkink","year":"2018","unstructured":"Mokkink LB, De Vet HC, Prinsen CA, Patrick DL, Alonso J, Bouter LM, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1171\u20139.","journal-title":"Qual Life Res"},{"issue":"1","key":"1994_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34\u201342.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1994_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-016-1555-2","volume":"17","author":"CA Prinsen","year":"2016","unstructured":"Prinsen CA, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M, et al. How to select outcome measurement instruments for outcomes included in a \u201cCore Outcome Set\u201d\u2013a practical guideline. Trials. 2016;17(1):1\u201310.","journal-title":"Trials"},{"issue":"3","key":"1994_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11136-009-9451-9","volume":"18","author":"LB Mokkink","year":"2009","unstructured":"Mokkink LB, Terwee CB, Stratford PW, Alonso J, Patrick DL, Riphagen I, et al. Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Qual Life Res. 2009;18(3):313\u201333.","journal-title":"Qual Life Res"},{"issue":"8","key":"1994_CR16","doi-asserted-by":"publisher","first-page":"e036038","DOI":"10.1136\/bmjopen-2019-036038","volume":"10","author":"S Lorente","year":"2020","unstructured":"Lorente S, Viladrich C, Vives J, Losilla J-M. Tools to assess the measurement properties of quality of life instruments: a meta-review. BMJ Open. 2020;10(8):e036038.","journal-title":"BMJ Open"},{"issue":"4","key":"1994_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11136-015-1122-4","volume":"25","author":"CB Terwee","year":"2016","unstructured":"Terwee CB, Prinsen C, Garotti MR, Suman A, De Vet H, Mokkink LB. The quality of systematic reviews of health-related outcome measurement instruments. Qual Life Res. 2016;25(4):767\u201379.","journal-title":"Qual Life Res"},{"key":"1994_CR18","unstructured":"Butcher NJ, Monsour A, Mokkink LB, Terwee CB, Tricco AC, Gagnier J et al. Needed: guidance for reporting knowledge synthesis studies on measurement properties of outcome measurement instruments in health research.\u00a0BMJ Open. 2020;10(9)."},{"issue":"1","key":"1994_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-11-32","volume":"11","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11(1):1\u20138.","journal-title":"Trials"},{"key":"1994_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2471\/BLT.07.045120","volume":"85","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85:867\u201372.","journal-title":"Bull World Health Organ"},{"issue":"12","key":"1994_CR21","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1373\/clinchem.2015.246280","volume":"61","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem. 2015;61(12):1446\u201352.","journal-title":"Clin Chem"},{"issue":"6","key":"1994_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijnurstu.2011.01.016","volume":"48","author":"J Kottner","year":"2011","unstructured":"Kottner J, Audig\u00e9 L, Brorson S, Donner A, Gajewski BJ, Hr\u00f3bjartsson A, et al. Guidelines for reporting reliability and agreement studies (GRRAS) were proposed. Int J Nurs Stud. 2011;48(6):661\u201371.","journal-title":"Int J Nurs Stud"},{"key":"1994_CR23","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ."},{"issue":"3","key":"1994_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1994_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/BF00540022","volume":"5","author":"M Staquet","year":"1996","unstructured":"Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res. 1996;5(5):496\u2013502.","journal-title":"Qual Life Res"},{"key":"1994_CR26","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1111\/j.1524-4733.2007.00274.x","volume":"10","author":"DA Revicki","year":"2007","unstructured":"Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, Santanello NC, et al. Interpreting and reporting results based on patient-reported outcomes. Value Health. 2007;10:S116\u2013S24.","journal-title":"Value Health"},{"issue":"8","key":"1994_CR27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jama.2013.879","volume":"309","author":"M Calvert","year":"2013","unstructured":"Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD, et al. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013;309(8):814\u201322.","journal-title":"JAMA"},{"key":"1994_CR28","volume-title":"Guidance for Industry - patient-reported outcome measures: use in medical product development to support labeling claims","author":"FDA","year":"2009","unstructured":"FDA. Guidance for Industry - patient-reported outcome measures: use in medical product development to support labeling claims: U.S. Department of Health and Human Services Food and Drug Administration; 2009."},{"issue":"8","key":"1994_CR29","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11136-012-0344-y","volume":"22","author":"BB Reeve","year":"2013","unstructured":"Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, et al. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013;22(8):1889\u2013905.","journal-title":"Qual Life Res"},{"issue":"6","key":"1994_CR30","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s11136-012-0252-1","volume":"22","author":"M Brundage","year":"2013","unstructured":"Brundage M, Blazeby J, Revicki D, Bass B, De Vet H, Duffy H, et al. Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. Qual Life Res. 2013;22(6):1161\u201375.","journal-title":"Qual Life Res"},{"key":"1994_CR31","volume-title":"The OMERACT handbook for establishing and implementing core outcomes in clinical trials across the spectrum of rheumatologic conditions","author":"OMERACT","year":"2021","unstructured":"OMERACT. The OMERACT handbook for establishing and implementing core outcomes in clinical trials across the spectrum of rheumatologic conditions. Ottawa: OMERACT; 2021."},{"key":"1994_CR32","volume-title":"Guidance for Measure Testing and Evaluating Scientific Acceptability of Measure Properties","author":"NQF","year":"2011","unstructured":"NQF. Guidance for Measure Testing and Evaluating Scientific Acceptability of Measure Properties. Washington DC: National Quality Forum; 2011."},{"issue":"3","key":"1994_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1023\/A:1015291021312","volume":"11","author":"KN Lohr","year":"2002","unstructured":"Lohr KN. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11(3):193\u2013205.","journal-title":"Qual Life Res"},{"issue":"4","key":"1994_CR34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MD McInnes","year":"2018","unstructured":"McInnes MD, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388\u201396.","journal-title":"JAMA."},{"issue":"16","key":"1994_CR35","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","volume":"313","author":"LA Stewart","year":"2015","unstructured":"Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, et al. Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313(16):1657\u201365.","journal-title":"JAMA."},{"key":"1994_CR36","doi-asserted-by":"publisher","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349. https:\/\/doi.org\/10.1136\/bmj.g7647.","DOI":"10.1136\/bmj.g7647"},{"issue":"7","key":"1994_CR37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"1994_CR38","volume-title":"Standards for Reporting Systematic Reviews. Finding what works in health care: standards for systematic reviews","author":"S Morton","year":"2011","unstructured":"Morton S, Berg A, Levit L, Eden J. Standards for Reporting Systematic Reviews. Finding what works in health care: standards for systematic reviews. Washington DC: Institute of Medicine; 2011."},{"key":"1994_CR39","volume-title":"Draft final research report: instructions for awardee","author":"PCORI","year":"2021","unstructured":"PCORI. Draft final research report: instructions for awardee. Washington DC: Patient-centered Outcomes Research Institute; 2021."},{"key":"1994_CR40","volume-title":"Methods guide for effectiveness and comparative effectiveness reviews","author":"AHRQ","year":"2019","unstructured":"AHRQ. Methods guide for effectiveness and comparative effectiveness reviews. Rockville: Agency for Healthcare Research and Quality; 2019. Contract No.: 10(14)-EHC063-EF"},{"key":"1994_CR41","volume-title":"CRD\u2019s guidance for undertaking reviews in health care","author":"CRD","year":"2009","unstructured":"CRD. CRD\u2019s guidance for undertaking reviews in health care. York: Centre for Reviews and Dissemination; 2009."},{"key":"1994_CR42","volume-title":"Methodological expectations of cochrane intervention reviews","author":"J Higgins","year":"2021","unstructured":"Higgins J, Lasserson T, Chandles J, Tovey D, Flemyng E, Churchill R. Methodological expectations of cochrane intervention reviews. London: Cochrane; 2021."},{"key":"1994_CR43","volume-title":"JBI Manual for evidence synthesis","author":"E Aromataris","year":"2020","unstructured":"Aromataris E, Munn Z. JBI Manual for evidence synthesis. Adelaide: JBI; 2020."},{"key":"1994_CR44","doi-asserted-by":"crossref","unstructured":"Stephenson M, Riitano D, Wilson S, Leonardi-Bee J, Mabire C, Cooper K, et al. Chapter 12: Systematic reviews of measurement properties. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. Adelaide: JBI; 2020.","DOI":"10.46658\/JBIRM-19-03"},{"issue":"8","key":"1994_CR45","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s11136-021-02822-4","volume":"30","author":"JJ Gagnier","year":"2021","unstructured":"Gagnier JJ, Lai J, Mokkink LB, Terwee CB. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res. 2021;30(8):2197\u2013219. https:\/\/doi.org\/10.1007\/s11136-021-02822-4.","journal-title":"Qual Life Res."},{"issue":"2","key":"1994_CR46","doi-asserted-by":"publisher","first-page":"e1000217","DOI":"10.1371\/journal.pmed.1000217","volume":"7","author":"D Moher","year":"2010","unstructured":"Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7(2):e1000217.","journal-title":"PLoS Med"},{"issue":"1","key":"1994_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-020-04440-w","volume":"21","author":"NJ Butcher","year":"2020","unstructured":"Butcher NJ, Mew EJ, Monsour A, Chan A-W, Moher D, Offringa M. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review. Trials. 2020;21(1):1\u201317.","journal-title":"Trials."},{"key":"1994_CR48","volume-title":"Systematic review on the measurement properties of diabetes-specific patient-reported outcome measures (PROMs) for measuring physical functioning in people with type 2 diabetes","author":"EB Elsman","year":"2021","unstructured":"Elsman EB, Mokkink LB, Langendoen-Gort M, Rutters F, Beulens JW, Elders P et al. Systematic review on the measurement properties of diabetes-specific patient-reported outcome measures (PROMs) for measuring physical functioning in people with type 2 diabetes 2021."},{"issue":"1","key":"1994_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-020-01647-y","volume":"19","author":"IL Abma","year":"2021","unstructured":"Abma IL, Butje BJ, Peter M, van der Wees PJ. Measurement properties of the Dutch\u2013Flemish patient-reported outcomes measurement information system (PROMIS) physical function item bank and instruments: a systematic review. Health Qual Life Outcomes. 2021;19(1):1\u201322.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"1994_CR50","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/15412555.2021.1945021","volume":"18","author":"A Mehdipour","year":"2021","unstructured":"Mehdipour A, Wiley E, Richardson J, Beauchamp M, Kuspinar A. The performance of digital monitoring devices for oxygen saturation and respiratory rate in COPD: A Systematic Review. COPD. 2021;18(4):469\u201375.","journal-title":"COPD"},{"issue":"4","key":"1994_CR51","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1365-2648.2003.02537.x","volume":"41","author":"C Powell","year":"2003","unstructured":"Powell C. The Delphi technique: myths and realities. J Adv Nurs. 2003;41(4):376\u201382.","journal-title":"J Adv Nurs"},{"issue":"4","key":"1994_CR52","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","volume":"19","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539\u201349.","journal-title":"Qual Life Res"},{"issue":"1","key":"1994_CR53","doi-asserted-by":"publisher","first-page":"e1000393","DOI":"10.1371\/journal.pmed.1000393","volume":"8","author":"IP Sinha","year":"2011","unstructured":"Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011;8(1):e1000393.","journal-title":"PLoS Med"},{"key":"1994_CR54","volume-title":"Group techniques for idea building","author":"CM Moore","year":"1987","unstructured":"Moore CM. Group techniques for idea building. Newbury Park: Sage Publications, Inc; 1987."},{"issue":"2","key":"1994_CR55","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"1994_CR56","unstructured":"COSMIN. The COSMIN initiative. www.cosmin.nl. Accessed 3 Feb 2022."},{"key":"1994_CR57","unstructured":"EQUATOR. The EQUATOR Network. https:\/\/www.equator-network.org\/. Accessed 15 Nov 2021."},{"key":"1994_CR58","unstructured":"PRISMA. http:\/\/www.prisma-statement.org\/. Accessed 10 Oct 2021."},{"key":"1994_CR59","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s12508-021-00316-9","volume":"99","author":"L Bavelaar","year":"2021","unstructured":"Bavelaar L, van Tol LS, Caljouw MA, van der Steen JT. Nederlandse vertaling en eerste stappen in validatie van de PPEET om burger-en pati\u00ebntenparticipatie te evalueren. Tijdschrift voor Gezondheidswetenschappen. 2021;99:146\u201353. https:\/\/doi.org\/10.1007\/s12508-021-00316-9.","journal-title":"Tijdschrift voor Gezondheidswetenschappen."},{"issue":"4","key":"1994_CR60","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/hex.12378","volume":"19","author":"J Abelson","year":"2016","unstructured":"Abelson J, Li K, Wilson G, Shields K, Schneider C, Boesveld S. Supporting quality public and patient engagement in health system organizations: development and usability testing of the P ublic and P atient E ngagement E valuation T ool. Health Expect. 2016;19(4):817\u201327.","journal-title":"Health Expect"},{"issue":"11","key":"1994_CR61","doi-asserted-by":"publisher","first-page":"e0206588","DOI":"10.1371\/journal.pone.0206588","volume":"13","author":"CB Hamilton","year":"2018","unstructured":"Hamilton CB, Hoens AM, McQuitty S, McKinnon AM, English K, Backman CL, et al. Development and pre-testing of the Patient Engagement In Research Scale (PEIRS) to assess the quality of engagement from a patient perspective. PLoS One. 2018;13(11):e0206588.","journal-title":"PLoS One"},{"issue":"1","key":"1994_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.apnr.2009.04.003","volume":"24","author":"JD Tariman","year":"2011","unstructured":"Tariman JD, Berry DL, Halpenny B, Wolpin S, Schepp K. Validation and testing of the Acceptability E-scale for web-based patient-reported outcomes in cancer care. Appl Nurs Res. 2011;24(1):53\u20138.","journal-title":"Appl Nurs Res"},{"issue":"40","key":"1994_CR63","doi-asserted-by":"publisher","first-page":"E1138","DOI":"10.1503\/cmaj.200193","volume":"192","author":"W Wiercioch","year":"2020","unstructured":"Wiercioch W, Akl EA, Santesso N, Zhang Y, Morgan RL, Yepes-Nu\u00f1ez JJ, et al. Assessing the process and outcome of the development of practice guidelines and recommendations: PANELVIEW instrument development. CMAJ. 2020;192(40):E1138\u2013E45.","journal-title":"CMAJ"},{"key":"1994_CR64","doi-asserted-by":"publisher","unstructured":"Korbel JO, Stegle O. Effects of the COVID-19 pandemic on life scientists.\u00a0Genome Biol. 2020;21:113. https:\/\/doi.org\/10.1186\/s13059-020-02031-1.","DOI":"10.1186\/s13059-020-02031-1"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-01994-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-022-01994-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-01994-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:13:58Z","timestamp":1668384838000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-022-01994-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1994"],"URL":"https:\/\/doi.org\/10.1186\/s13643-022-01994-5","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NB receives research funding from Canadian Institutes of Health Research, CHILD-BRIGHT, and the Cundill Centre for Child and Youth Depression. She also declares consulting fees from Nobias Therapeutics, Inc. LM and CT are one of the founders of the COSMIN initiative. OLA receives funding from the NIHR Birmingham Biomedical Research Centre (BRC), NIHR Applied Research Collaboration (ARC) West Midlands, Innovate UK (part of UK Research and Innovation), Janssen, Gilead, and GSK. OLA also declares personal fees from Gilead Sciences Ltd., GlaxoSmithKline (GSK) and Merck. CB has received funding from US Department of Defense, MGNet, Muscular Dystrophy Canada, Octapharma and Grifols. She has been consultant for Alexion, CSL, Sanofi, and Argenx. She is the primary developer of the MGII, and may receive royalties. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}